320
Views
24
CrossRef citations to date
0
Altmetric
Original Articles

Inhibition of proliferative responses of mouse spleen lymphocytes by lacto‐ and ovotransferrins

&
Pages 193-201 | Received 01 Jul 1996, Accepted 01 Mar 1997, Published online: 16 Sep 2008
 

Abstract

This study evaluated the influence of three transferrin family proteins (bovine lactotransfer‐rin, bLf; chicken ovotransferrin, cOf; quail ovotransferrin, qOf) at concentrations ranging from 10 to 50 fig ml‐1 on proliferative responses of mouse spleen lymphocytes stimulated by lipopolysaccharide (LPS) and phytohemagglutinin (PHA). The transferrins significantly inhibited both the mitogen‐induced proliferation in a dose‐dependent manner. Ovotransferrins, especially qOf, had cytotoxicity for the lymphocytes. There is no relationship between iron saturation and inhibitory effect of each transferrin or cytotoxicity of ovotransferrins. All these transferrins bound to CD4+ T‐lymphocytes, CD8+ T‐lymphocytes and B‐lymphocytes, but no transferrin conjugated with PHA. PHA bound to lymphocytes previously incubated with each transferrin. These results indicate that the inhibition of proliferation by the transferrins and the cytoxicity of ovotransferrins are not attributable to a function of iron transport and to inactivation of mitogen, suggesting that the hyporesponsiveness is due to interaction of lymphocytes and/or accessory cells with each transferrin.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.